February 19, 2026 a 08:00 am
JNJ: Fundamental Ratio Analysis - Johnson & Johnson
Johnson & Johnson remains a stable force in the healthcare sector, transitioning its focus to innovative medicine and advanced technology in MedTech. This strategic shift highlights its commitment to growth, but also introduces exposure to high-stakes regulatory environments in pharmaceuticals and medical devices.
Fundamental Rating
Johnson & Johnson has a solid fundamental rating, reflecting strong financial health and growth potential. Below are the ratings in various categories.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 2 | |
| Price To Earnings | 3 | |
| Price To Book | 1 |
Historical Rating
The historical performance provides insights into Johnson & Johnson's stability over time. The consistency in scores reflects its resilient business model.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | 4 | 4 | 5 | 5 | 2 | 3 | 1 |
| (Past) | 0 | 4 | 5 | 5 | 2 | 3 | 1 |
Analysts' Price Targets
Analysts have set a positive outlook with a consensus "Buy" rating, reflecting confidence in the stock's upward trajectory.
| High | Low | Median | Consensus |
|---|---|---|---|
| $265 | $190 | $220 | $229.33 |
Analyst Sentiment
The sentiment among analysts suggests a favorable view of Johnson & Johnson's performance, with a significant push towards "Buy" recommendations.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 20 | |
| Hold | 16 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Johnson & Johnson presents a robust investment option, driven by its strategic pivot towards innovative medicine and MedTech devices. The fundamental ratings indicate financial health, while analyst sentiments support future growth prospects. While existing regulatory risks in pharmaceuticals and medical devices pose challenges, the overall adaptive strategies by the company showcase a promising future for shareholders. The "Buy" consensus reflects market confidence in navigating these dynamics effectively.